financetom
Business
financetom
/
Business
/
Australia's Westpac to hire 350 more bankers to win business lending market share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Australia's Westpac to hire 350 more bankers to win business lending market share
Sep 1, 2025 9:34 PM

SYDNEY (Reuters) -Australia's Westpac Banking Corp aims to hire 350 bankers in the next two years to help gain business banking market share and close the gap on its major rivals, it said on Tuesday.

The bank had hired 135 business bankers so far this year, Paul Fowler, Westpac's chief executive of business banking and wealth told an analyst briefing.

Westpac, Australia's second-largest bank by market capitalisation, had a 16.1% business lending market share in July, up from 15.3% the same time last year, according to regulatory figures released last week.

It sits third behind National Australia Bank with 21.6% and the country's largest lender, Commonwealth Bank, with 18.85%, the figures showed.

Westpac and CBA are targeting NAB's stronghold on business banking by offering reduced lending rates to get customers to switch banks, according to analysts, at a time when the bank is undergoing major change.

NAB's business banking head Andrew Auerbach began in June and has previously not run a business banking division and that makes it vulnerable to competitors trying to pinch market share, analysts say.

NAB will hold a business banking briefing on Wednesday.

Fowler said Westpac's business and wealth division recorded a net profit of A$1.1 billion ($714.78 million) in the first half of the current financial year, making it the largest contributor to the bank's A$3.3 billion net profit.

"Almost a decade ago, Westpac held a leading position in business banking in this country. Since that time, we've had times where we lost focus and we've conceded considerable ground," Fowler said.

"... we've made a decision, a strategic decision, to tilt towards business banking."

Fowler joined Westpac in May after 10 years at CBA.

($1 = 1.5389 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Matthews International Fiscal Q4 Adjusted Earnings, Revenue Fall
Matthews International Fiscal Q4 Adjusted Earnings, Revenue Fall
Nov 20, 2025
04:27 PM EST, 11/20/2025 (MT Newswires) -- Matthews International ( MATW ) reported fiscal Q4 adjusted earnings late Thursday of $0.50 per share, down from $0.55 a year earlier. Two analysts polled by FactSet expected $0.20. Revenue for the three months ended Sept. 30 was $318.8 million, down from $446.7 million a year earlier. Two analysts surveyed by FactSet expected...
Atlassian Insider Sold Shares Worth $444,896, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $444,896, According to a Recent SEC Filing
Nov 20, 2025
04:30 PM EST, 11/20/2025 (MT Newswires) -- Rajeev Bashyam Rajan, Chief Technology Officer, on November 19, 2025, sold 3,017 shares in Atlassian ( TEAM ) for $444,896. Following the Form 4 filing with the SEC, Rajan has control over a total of 219,997 Class A common shares of the company, with 219,997 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000194361425000004/xslF345X05/primarydocument.xml ...
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing
Nov 20, 2025
04:29 PM EST, 11/20/2025 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on November 18, 2025, sold 20,000 shares in Revolution Medicines ( RVMD ) for $1,407,586. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 958,761 common shares of the company, with 247,863 shares held directly and 710,898 controlled...
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing
Nov 20, 2025
04:29 PM EST, 11/20/2025 (MT Newswires) -- Jeff Cislini, General Counsel, on November 18, 2025, sold 13,388 shares in Revolution Medicines ( RVMD ) for $939,008. Following the Form 4 filing with the SEC, Cislini has control over a total of 50,425 common shares of the company, with 50,425 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071725000383/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved